Breast Cancer
Vitamin A Derivative May Help Protect Young Women
Published in Women's Health Weekly, November 2nd, 2000
A clinical trial with a vitamin A derivative, fenretinide, has provided firm evidence that it protects younger patients in early stages of the disease against the formation of a second breast cancer. The result now points the way to the drug being used as a preventive in healthy young women at high risk of developing cancer.
Dr. Alberto Costa from the European Institute of Oncology Breast Division in Milan, Italy, said that in a multi-center trial in Italy of nearly 3,000 women with stage I breast cancer, half were randomized after surgery to receive five...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Younger Patients Benefit from Radiation Boost - Osteoporosis
Water Fluoridation Reduces Risk of Bone Fractures, Benefits/Risks in Children Need Further Study - At-Risk Populations
Women Sexually Abused as Children at Increased Risk of Developing Psychiatric Illnesses - Breast Cancer
Caution Advised in Prescribing HRT for Survivors - Breast Cancer
DNA "Photofits" for Tumors: The Future of Treatment? - Breast Cancer
Disease is Also Aggressive in Elderly Women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
